Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19

Leila T. Tchelebi, Karin Haustermans, Marta Scorsetti, Ali Hosni, Florence Huguet, Maria A. Hawkins, Laura A. Dawson, Karyn A. Goodman

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

As of April 6, 2020, there are over 1,200,000 reported cases and 70,000 deaths worldwide due to COVID-19, the disease caused by the SARS-CoV-2 virus, and these numbers rise exponentially by the day [1]. According to the Centers for Disease Control (CDC), the most effective means of minimizing the spread of the virus is through reducing interactions between individuals [2]. We performed a review of the literature, as well as national and international treatment guidelines, seeking data in support of the RADS principle (Remote visits, Avoid radiation, Defer radiation, Shorten radiation) [3] as it applies to gastrointestinal cancers. The purpose of the present work is to guide radiation oncologists managing patients with gastrointestinal cancers during the COVID-19 crisis in order to maintain the safety of our patients, while minimizing the impact of the pandemic on cancer outcomes.

Original languageEnglish (US)
Pages (from-to)194-200
Number of pages7
JournalRadiotherapy and Oncology
Volume148
DOIs
StatePublished - Jul 2020

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19'. Together they form a unique fingerprint.

  • Cite this